NewTimeSpace News: EDDING GENOR GROUPannounced in a July 2 announcement that the Investigational New Drug (IND) application for GB268, its highly differentiated innovative PD-1/CTLA-4/VEGF trispecific antibody, has been approved by the National Medical Products Administration (NMPA) for a Phase Ib/II clinical trial treating locally advanced unresectable or metastatic breast cancer.
NewTimeSpace News: Dajin Heavy Industry announced on July 2 that the stabilisation period for its global offering has come to an end. The joint sponsors and global co-ordinator partially exercised the over-allotment option in respect of 2,325,900 H Shares at HK$66.40 per share, generating additional net proceeds of approximately HK$151 million.
NewTimeSpace News: Estun disclosed in an announcement dated July 2 that the cumulative deviation of closing price increase of the Company’s shares exceeded 20% across three consecutive trading days, namely June 30, July 1 and July 2, constituting abnormal fluctuation in share trading.
NewTimeSpace News: Hanx Biopharmaceuticals announced on July 2 that the Company has signed a cooperation agreement with Swiss biotechnology firm TwinEdge Bioscience to conduct translational medical research on its core bispecific antibody candidate HX009 leveraging AI technologies.
NewTimeSpace News: Lancang Ancient Tea announced on July 2 that the company and its subsidiary Guangzhou Kangrui have received a first-instance judgment in a relevant lawsuit, ordering them to refund RMB 30 million in payment for goods, pay liquidated damages of RMB 1 million together with related interest and litigation costs.
NewTimeSpace News: Jiangxi Institute of Biological Products Inc.announced on July 3 that Chifeng Boen Pharmaceutical, its wholly-owned subsidiary, has recently obtained the Official Approval Document for veterinary tetanus antitoxin product registration number.
NewTimeSpace News: Brii Biosciences announced on July 3 the end-of-treatment results from its Phase 2b ENRICH and ENHANCE studies. Data from the ENRICH trial showed that regimens with initial BRII-179 followed by combination therapy of elebsiran and PEG-IFNα achieved HBsAg clearance rates of 42.9% and 40.0% respectively.
NewTimeSpace News: On July 3, 51World announced that the Company has entered into a placing agreement with the placing agent. It proposes to place 5,465,600 new H shares at a placing price of HK$73.20 per share, with total gross proceeds expected to be approximately HK$400.1 million.
Guming Holdings completed the issuance of HK$1.96 billion zero-coupon guaranteed convertible bonds on July 2, 2026, and will seek listing on the Vienna Stock Exchange. The net proceeds of approximately HK$1.9625 billion will be allocated with roughly 40% for share repurchases, 30% for debt repayment, 20% for raw materials and equipment procurement, and 10% for R&D and overseas expansion, to be fully utilized by June 30, 2027.
Brightstar Technology Group proposes a 20-for-1 share consolidation to maintain its authorized share capital at HK$30 million while reducing issued shares from 1.125 billion to approximately 56.3 million, with the board lot remaining at 2,000 shares. The move aims to address the share price trading below HK$0.15 and comply with GEM listing requirements, subject to shareholder and Stock Exchange approval, with an expected effective date of July 31, 2026.
Perfect Optronics expects to recognize an estimated fair value loss of approximately HK$4.34 million on its Mobvoi investment for the six months ended June 30, 2026, narrowing from a loss of HK$7.06 million in the same period last year. The fair value of its Mobvoi holdings dropped to approximately HK$5.58 million from HK$9.91 million at year-end, and the figures remain unaudited as consolidated results are being prepared.
By the close of trading on Jul 2, 2026, ALEBUND-B(09637.HK) saw a loss of 44.47% in its share price, closing at HKD 25.5. During the session, it reached an intraday high of HKD 39.04 and touched an intraday low of HKD 22.72.
By the close of trading on Jul 2, 2026, ANKER(00668.HK) saw a gain of 15.69% in its share price, closing at HKD 114.9. and touched an intraday low of HKD 90.
By the close of trading on Jul 2, 2026, KNOWLEDGE ATLAS(02513.HK) saw a loss of 16.64% in its share price, closing at HKD 1754. During the session, it reached an intraday high of HKD 2160 and touched an intraday low of HKD 1711.
MIDEA GROUP(00300.HK) will spend CNY 111.24 million to repurchase 1.44 million shares on Jul 2, 2026 .
NewTimeSpace News: By the close of trading on Jul 2, 2026, HJ SCIENCE-B(06132.HK) saw a gain of 15.38% in its share price, closing at HKD 41.4. During the session, it reached an intraday high of HKD 42.98 and touched an intraday low of HKD 34.6.
